Psyence Group Launches its Functional Mushroom Brand, “Goodmind”

NEXT STORY
ADMA Biologics to Participate in the Jefferies Virtual Plasma Summit
PREV STORY
Apollomics, Inc. Announces Successful Enrollment of First Patient Into Phase 1 Clinical Trial of APL-106 (Uproleselan Injection) in China
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Roche receives positive CHMP opinion for Gavreto® (pralsetinib) for the treatment of adults with RET fusion-positive advanced non-small cell lung cancer

author_avatar
NASDAQ Market News

Forty Seven, Inc. Announces Updated Data from Phase 1b/2 Clinical Trial of 5F9 in Combination with Rituximab in Patients with Relapsed/Refractory Non-Hodgkin’s Lymphoma

author_avatar
NASDAQ Market News

Curis to Release First Quarter 2017 Financial Results and Hold Conference Call on May 4, 2017

LEXINGTON, Mass., April 28, 2017 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), a biotechnology company ...

author_avatar
NASDAQ Market News